Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor α

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Sep 19

PMID 26383638

Citations 15

Authors

Hiroshi Matsuoka

Akiho Shima

Daisuke Kuramoto

Daisuke Kikumoto

Takashi Matsui

Akihiro Michihara

Affiliations

Soon will be listed here.

Abstract

Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes a committed and rate-limiting step in hepatic gluconeogenesis, and its activity is tightly regulated to maintain blood glucose levels within normal limits. PEPCK activity is primarily regulated through hormonal control of gene transcription. Transcription is additionally regulated via a cAMP response unit, which includes a cAMP response element and four binding sites for CCAAT/enhancer-binding protein (C/EBP). Notably, the cAMP response unit also contains a putative response element for retinoic acid receptor-related orphan receptor α (RORα). In this paper, we characterize the effect of the RORα response element on cAMP-induced transcription. Electrophoresis mobility shift assay indicates that RORα binds this response element in a sequence-specific manner. Furthermore, luciferase reporter assays indicate that RORα interacts with C/EBP at the PEPCK promoter to synergistically enhance transcription. We also found that cAMP-induced transcription depends in part on RORα and its response element. In addition, we show that suppression of RORα by siRNA significantly decreased PEPCK transcription. Finally, we found that a RORα antagonist inhibits hepatic gluconeogenesis in an in vitro glucose production assay. Taken together, the data strongly suggest that PEPCK is a direct RORα target. These results define possible new roles for RORα in hepatic gluconeogenesis.

Citing Articles

Hyperpolarized [2-C, 3-H]Pyruvate Detects Hepatic Gluconeogenesis .

Huynh M, Erfani Z, Kovacs Z, Park J ACS Sens. 2024; 9(6):2801-2805.

PMID: 38838349 PMC: 11227886. DOI: 10.1021/acssensors.4c00734.

The Safety and Efficacy of Combining Saxagliptin and Pioglitazone Therapy in Streptozocin-Induced Diabetic Rats.

Othman A, Ashour Ibrahim I, Saleh S, Abo-Elmatty D, Mesbah N, Abdel-Hamed A Biomedicines. 2023; 11(12).

PMID: 38137521 PMC: 10741989. DOI: 10.3390/biomedicines11123300.

Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families.

Al Busaidi M, Mohamed F, Al-Ajmi E, Al Hashmi N, Al-Thihli K, Al Futaisi A Orphanet J Rare Dis. 2023; 18(1):344.

PMID: 37924129 PMC: 10625263. DOI: 10.1186/s13023-023-02946-5.

Chronic Glucocorticoid Exposure Induced an S1PR2-RORγ Axis to Enhance Hepatic Gluconeogenesis in Male Mice.

Lee R, Chang M, Tsay A, Lee Y, Li D, Yiv N Diabetes. 2023; 72(11):1534-1546.

PMID: 37552863 PMC: 10588286. DOI: 10.2337/db22-0605.

Exploiting Multi-Omics Profiling and Systems Biology to Investigate Functions of TOMM34.

Poverennaya E, Pyatnitskiy M, Dolgalev G, Arzumanian V, Kiseleva O, Kurbatov I Biology (Basel). 2023; 12(2).

PMID: 36829477 PMC: 9952762. DOI: 10.3390/biology12020198.

References

Roesler W . The role of C/EBP in nutrient and hormonal regulation of gene expression. Annu Rev Nutr. 2001; 21:141-65. DOI: 10.1146/annurev.nutr.21.1.141. View

Chopra A, Louet J, Saha P, An J, DeMayo F, Xu J . Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science. 2008; 322(5906):1395-9. PMC: 2668604. DOI: 10.1126/science.1164847. View

Kuang J, Hou X, Zhang J, Chen Y, Su Z . Identification of insulin as a novel retinoic acid receptor-related orphan receptor α target gene. FEBS Lett. 2014; 588(6):1071-9. DOI: 10.1016/j.febslet.2014.02.029. View

Delerive P, Monte D, Dubois G, Trottein F, Fruchart-Najib J, Mariani J . The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep. 2001; 2(1):42-8. PMC: 1083804. DOI: 10.1093/embo-reports/kve007. View

Kojetin D, Wang Y, Kamenecka T, Burris T . Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem Biol. 2010; 6(2):131-4. PMC: 3042041. DOI: 10.1021/cb1002575. View

Solt L, Banerjee S, Campbell S, Kamenecka T, Burris T . ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes. Endocrinology. 2015; 156(3):869-81. PMC: 4330305. DOI: 10.1210/en.2014-1677. View

Wada T, Kang H, Angers M, Gong H, Bhatia S, Khadem S . Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol. 2007; 73(3):891-9. DOI: 10.1124/mol.107.040741. View

Akashi M, Takumi T . The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol. 2005; 12(5):441-8. DOI: 10.1038/nsmb925. View

Acquaah-Mensah G, Agu N, Khan T, Gardner A . A regulatory role for the insulin- and BDNF-linked RORA in the hippocampus: implications for Alzheimer's disease. J Alzheimers Dis. 2014; 44(3):827-38. DOI: 10.3233/JAD-141731. View

10.

Huh J, Littman D . Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur J Immunol. 2012; 42(9):2232-7. PMC: 3609417. DOI: 10.1002/eji.201242740. View

11.

Tuong Z, Lau P, Yeo J, Pearen M, Wall A, Stanley A . Disruption of Rorα1 and cholesterol 25-hydroxylase expression attenuates phagocytosis in male Rorαsg/sg mice. Endocrinology. 2012; 154(1):140-9. DOI: 10.1210/en.2012-1889. View

12.

Mamontova A, Esposito B, Chaniale C, Bouly M, Delhaye-Bouchaud N, Luc G . Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation. 1998; 98(24):2738-43. DOI: 10.1161/01.cir.98.24.2738. View

13.

Giguere V, Tini M, Flock G, Ong E, Evans R, Otulakowski G . Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 1994; 8(5):538-53. DOI: 10.1101/gad.8.5.538. View

14.

Choudhury M, Qadri I, Rahman S, Schroeder-Gloeckler J, Janssen R, Friedman J . C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells. Mol Cell Endocrinol. 2010; 331(1):102-8. PMC: 2981635. DOI: 10.1016/j.mce.2010.08.014. View

15.

Roesler W, Graham J, Kolen R, Klemm D, McFie P . The cAMP response element binding protein synergizes with other transcription factors to mediate cAMP responsiveness. J Biol Chem. 1995; 270(14):8225-32. DOI: 10.1074/jbc.270.14.8225. View

16.

Okamoto K, Iwai Y, Oh-Hora M, Yamamoto M, Morio T, Aoki K . IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature. 2010; 464(7293):1381-5. DOI: 10.1038/nature08922. View

17.

Yin L, Wu N, Curtin J, Qatanani M, Szwergold N, Reid R . Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science. 2007; 318(5857):1786-9. DOI: 10.1126/science.1150179. View

18.

Imai E, Miner J, Mitchell J, Yamamoto K, GRANNER D . Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem. 1993; 268(8):5353-6. View

19.

Guillaumond F, Dardente H, Giguere V, Cermakian N . Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms. 2005; 20(5):391-403. DOI: 10.1177/0748730405277232. View

20.

Park E, Gurney A, Nizielski S, Hakimi P, Cao Z, Moorman A . Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J Biol Chem. 1993; 268(1):613-9. View